Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116738469> ?p ?o ?g. }
- W2116738469 endingPage "90" @default.
- W2116738469 startingPage "81" @default.
- W2116738469 abstract "Tepoxalin is a novel dual inhibitor of cyclooxygenase (CO) and lipoxygenase (LO) pathways of arachidonic acid metabolism with a relative lack of gastrointestinal side effects within its preclinical therapeutic dose range. The present study investigated the antinociceptive action of tepoxalin and its primary (carboxylic acid) metabolite (RWJ 20142) in several acute tests in mice and rats. Tepoxalin produced dose-related, non-opioid (i.e., naloxone-insensitive) antinociception in the mouse acetylcholine (ACh) induced abdominal irritant test (AIT) with an onset within 15 min and an exceptional duration (about 12 h). The oral ED50 value at peak effect (30 min) was 0.3 mg/kg (0.8 μmol/kg), compared to 0.9, 38.0, and 164 mg/kg (2.5, 160.8, and 1, 085 μmol/kg), respectively, for indomethacin, zileuton, and acetaminophen. Tepoxalin was inactive via intracerebroventricular (i.c.v.) administration (up to 200μg) or (up to 100mg/kg [259 μg/kg] p.o. or s.c.) in the endothelin-1 (ET-1) AIT and mouse 48°C hot-plate tests. RWJ 20142 (a CO inhibitor), produced dose-related, non-opioid antinociception in the ACh test following oral (ED50 = 0.3 mg/kg [0.8 μmol/kg] at 30 min) or i.c.v. administration (ED50 = 3.3 μg [0.1 μmol] at 15 min) and was active p.o. in the phenyl-p -quinone (PpQ) (ED50 = 0.2 mg/kg [0.6 μmol/kg] at 30 min) and ET-1 tests (ED50 = 19.6 mg/kg [54.9 μmol/kg] at 30 min). It was the only compound active p.o. in the 48°C hot-plate test and was significantly more potent than tepoxalin in the rat air-induced AIT. Measurement of plasma levels suggests RWJ 20142 might be a major contributor to tepoxalin-induced antinociception. The inactivity of tepoxalin in the ET-1 test suggests a separate antinociceptive action of the parent compound. In summary, it appears that both tepoxalin and its primary metabolite contribute to tepoxalin-induced antinociception in rodents, possibly by different mechanisms or at different sites, i.e., peripheral vs. central. © 1995 Wiley-Liss, Inc." @default.
- W2116738469 created "2016-06-24" @default.
- W2116738469 creator A5006932556 @default.
- W2116738469 creator A5014810432 @default.
- W2116738469 creator A5038511737 @default.
- W2116738469 creator A5042498949 @default.
- W2116738469 creator A5068993076 @default.
- W2116738469 creator A5077593052 @default.
- W2116738469 creator A5077900746 @default.
- W2116738469 date "1995-10-01" @default.
- W2116738469 modified "2023-09-25" @default.
- W2116738469 title "Antinociceptive effects of a novel dual cyclooxygenase/5-lipoxygenase inhibitor (tepoxalin) and its primary (carboxylic acid) metabolite (RWJ 20142) in acute tests in mice and rats" @default.
- W2116738469 cites W1505626165 @default.
- W2116738469 cites W1969927128 @default.
- W2116738469 cites W1987709173 @default.
- W2116738469 cites W1998162142 @default.
- W2116738469 cites W1999626606 @default.
- W2116738469 cites W2003375228 @default.
- W2116738469 cites W2017092509 @default.
- W2116738469 cites W2025017675 @default.
- W2116738469 cites W2026799598 @default.
- W2116738469 cites W2034102455 @default.
- W2116738469 cites W2035274118 @default.
- W2116738469 cites W2038096215 @default.
- W2116738469 cites W2048960401 @default.
- W2116738469 cites W2061616870 @default.
- W2116738469 cites W2063872501 @default.
- W2116738469 cites W2065588802 @default.
- W2116738469 cites W2073134794 @default.
- W2116738469 cites W2088637181 @default.
- W2116738469 cites W2116150465 @default.
- W2116738469 cites W2186004090 @default.
- W2116738469 doi "https://doi.org/10.1002/ddr.430360203" @default.
- W2116738469 hasPublicationYear "1995" @default.
- W2116738469 type Work @default.
- W2116738469 sameAs 2116738469 @default.
- W2116738469 citedByCount "1" @default.
- W2116738469 crossrefType "journal-article" @default.
- W2116738469 hasAuthorship W2116738469A5006932556 @default.
- W2116738469 hasAuthorship W2116738469A5014810432 @default.
- W2116738469 hasAuthorship W2116738469A5038511737 @default.
- W2116738469 hasAuthorship W2116738469A5042498949 @default.
- W2116738469 hasAuthorship W2116738469A5068993076 @default.
- W2116738469 hasAuthorship W2116738469A5077593052 @default.
- W2116738469 hasAuthorship W2116738469A5077900746 @default.
- W2116738469 hasConcept C170493617 @default.
- W2116738469 hasConcept C181199279 @default.
- W2116738469 hasConcept C185592680 @default.
- W2116738469 hasConcept C202751555 @default.
- W2116738469 hasConcept C2777477808 @default.
- W2116738469 hasConcept C2778078955 @default.
- W2116738469 hasConcept C2778750930 @default.
- W2116738469 hasConcept C2779689624 @default.
- W2116738469 hasConcept C2780820201 @default.
- W2116738469 hasConcept C2781063702 @default.
- W2116738469 hasConcept C2781370401 @default.
- W2116738469 hasConcept C42533223 @default.
- W2116738469 hasConcept C55493867 @default.
- W2116738469 hasConcept C71924100 @default.
- W2116738469 hasConcept C90342290 @default.
- W2116738469 hasConcept C98274493 @default.
- W2116738469 hasConceptScore W2116738469C170493617 @default.
- W2116738469 hasConceptScore W2116738469C181199279 @default.
- W2116738469 hasConceptScore W2116738469C185592680 @default.
- W2116738469 hasConceptScore W2116738469C202751555 @default.
- W2116738469 hasConceptScore W2116738469C2777477808 @default.
- W2116738469 hasConceptScore W2116738469C2778078955 @default.
- W2116738469 hasConceptScore W2116738469C2778750930 @default.
- W2116738469 hasConceptScore W2116738469C2779689624 @default.
- W2116738469 hasConceptScore W2116738469C2780820201 @default.
- W2116738469 hasConceptScore W2116738469C2781063702 @default.
- W2116738469 hasConceptScore W2116738469C2781370401 @default.
- W2116738469 hasConceptScore W2116738469C42533223 @default.
- W2116738469 hasConceptScore W2116738469C55493867 @default.
- W2116738469 hasConceptScore W2116738469C71924100 @default.
- W2116738469 hasConceptScore W2116738469C90342290 @default.
- W2116738469 hasConceptScore W2116738469C98274493 @default.
- W2116738469 hasIssue "2" @default.
- W2116738469 hasLocation W21167384691 @default.
- W2116738469 hasOpenAccess W2116738469 @default.
- W2116738469 hasPrimaryLocation W21167384691 @default.
- W2116738469 hasRelatedWork W1911727939 @default.
- W2116738469 hasRelatedWork W1962511894 @default.
- W2116738469 hasRelatedWork W1964028986 @default.
- W2116738469 hasRelatedWork W1977216415 @default.
- W2116738469 hasRelatedWork W1998219778 @default.
- W2116738469 hasRelatedWork W2003136932 @default.
- W2116738469 hasRelatedWork W2026913910 @default.
- W2116738469 hasRelatedWork W2059470734 @default.
- W2116738469 hasRelatedWork W2060607079 @default.
- W2116738469 hasRelatedWork W2085562939 @default.
- W2116738469 hasRelatedWork W2094156306 @default.
- W2116738469 hasRelatedWork W2154854365 @default.
- W2116738469 hasRelatedWork W2273041345 @default.
- W2116738469 hasRelatedWork W2302752766 @default.
- W2116738469 hasRelatedWork W2322243860 @default.
- W2116738469 hasRelatedWork W2360081972 @default.
- W2116738469 hasRelatedWork W2395823735 @default.